These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 11465392)
1. Human adult and foetal liver sulphotransferases: inhibition by mefenamic acid and salicylic acid. Vietri M; Pietrabissa A; Mosca F; Rane A; Pacific GM Xenobiotica; 2001 Mar; 31(3):153-61. PubMed ID: 11465392 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature. Pacifici GM Int J Clin Pharmacol Ther; 2004 Sep; 42(9):488-95. PubMed ID: 15487807 [TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of hepatic and duodenal sulfation of (-)-salbutamol and minoxidil by mefenamic acid. Vietri M; Pietrabissa A; Spisni R; Mosca F; Pacifici GM Eur J Clin Pharmacol; 2000 Sep; 56(6-7):477-9. PubMed ID: 11049010 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of phenol sulfotransferase (SULT1A1) by quercetin in human adult and foetal livers. De Santi C; Pietrabissa A; Mosca F; Rane A; Pacifici GM Xenobiotica; 2002 May; 32(5):363-8. PubMed ID: 12065059 [TBL] [Abstract][Full Text] [Related]
5. Sulfation of R(-)-apomorphine in the human liver and duodenum, and its inhibition by mefenamic acid, salicylic acid and quercetin. Vietri M; Vaglini F; Pietrabissa A; Spisni R; Mosca F; Pacifici GM Xenobiotica; 2002 Jul; 32(7):587-94. PubMed ID: 12162854 [TBL] [Abstract][Full Text] [Related]
6. Characterization of human sulfotransferases catalyzing the formation of p-cresol sulfate and identification of mefenamic acid as a potent metabolism inhibitor and potential therapeutic agent for detoxification. Rong Y; Kiang TKL Toxicol Appl Pharmacol; 2021 Aug; 425():115553. PubMed ID: 33915121 [TBL] [Abstract][Full Text] [Related]
7. Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. De Santi C; Pietrabissa A; Spisni R; Mosca F; Pacifici GM Xenobiotica; 2000 Jun; 30(6):609-17. PubMed ID: 10923862 [TBL] [Abstract][Full Text] [Related]
8. Fenamates and the potent inhibition of human liver phenol sulphotransferase. Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM Xenobiotica; 2000 Feb; 30(2):111-6. PubMed ID: 10718119 [TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine. Marchetti F; De Santi C; Vietri M; Pietrabissa A; Spisni R; Mosca F; Pacifici GM Xenobiotica; 2001 Dec; 31(12):841-7. PubMed ID: 11780759 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs. Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM Eur J Clin Pharmacol; 2000 Apr; 56(1):81-7. PubMed ID: 10853883 [TBL] [Abstract][Full Text] [Related]
11. Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues. Vietri M; Pietrabissa A; Mosca F; Spisni R; Pacifici GM Xenobiotica; 2003 Apr; 33(4):357-63. PubMed ID: 12745871 [TBL] [Abstract][Full Text] [Related]
12. Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. Barnett AC; Tsvetanov S; Gamage N; Martin JL; Duggleby RG; McManus ME J Biol Chem; 2004 Apr; 279(18):18799-805. PubMed ID: 14871892 [TBL] [Abstract][Full Text] [Related]
13. Polychlorobiphenylols are selective inhibitors of human phenol sulfotransferase 1A1 with 4-nitrophenol as a substrate. Wang LQ; Lehmler HJ; Robertson LW; James MO Chem Biol Interact; 2006 Feb; 159(3):235-46. PubMed ID: 16413005 [TBL] [Abstract][Full Text] [Related]
14. (-)-salbutamol sulphation in the human liver and duodenal mucosa: interindividual variability. Pacifici GM; Giulianetti B; Quilici MC; Spisni R; Nervi M; Giuliani L; Gomeni R Xenobiotica; 1997 Mar; 27(3):279-86. PubMed ID: 9141235 [TBL] [Abstract][Full Text] [Related]
15. Phenotype-genotype relationships of SULT1A1 in human liver and variations in the IC50 of the SULT1A1 inhibitor quercetin. Rossi AM; Maggini V; Fredianelli E; Di Bello D; Pietrabissa A; Mosca F; Barale R; Pacifici GM Int J Clin Pharmacol Ther; 2004 Oct; 42(10):561-7. PubMed ID: 15516026 [TBL] [Abstract][Full Text] [Related]
16. Phenol sulfotransferase 1A1 activity in human liver: kinetic properties, interindividual variation and re-evaluation of the suitability of 4-nitrophenol as a probe substrate. Tabrett CA; Coughtrie MW Biochem Pharmacol; 2003 Dec; 66(11):2089-97. PubMed ID: 14609733 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies. Brix LA; Barnett AC; Duggleby RG; Leggett B; McManus ME Biochemistry; 1999 Aug; 38(32):10474-9. PubMed ID: 10441143 [TBL] [Abstract][Full Text] [Related]
18. Expression and functional activities of selected sulfotransferase isoforms in BeWo cells and primary cytotrophoblast cells. Mitra P; Audus KL Biochem Pharmacol; 2009 Dec; 78(12):1475-82. PubMed ID: 19646966 [TBL] [Abstract][Full Text] [Related]
19. The NSAID allosteric site of human cytosolic sulfotransferases. Wang T; Cook I; Leyh TS J Biol Chem; 2017 Dec; 292(49):20305-20312. PubMed ID: 29038294 [TBL] [Abstract][Full Text] [Related]
20. Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition. Vuralli D; Arslan B; Topa E; de Morais AL; Gulbahar O; Ayata C; Bolay H J Headache Pain; 2022 Mar; 23(1):36. PubMed ID: 35282834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]